Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Clinical trial NCT05267535 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05267535
- Sponsor
- Neurim Pharmaceuticals Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-12
- Primary completion
- 2025-06-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.